iBio
IBIO • AMEX • Stock Fundamentals
iBio is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Martin Brenner, with a market cap of $90.4M.
Market Cap$90.4M
Employees23.0
CEOMartin Brenner
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
iBio FAQ
Common questions about iBio
iBio (IBIO) has a market capitalization of $90.4M and trades on AMEX.
iBio has approximately 23 employees.